期刊文献+

维持性血液透析患者透析间期血压节律影响因素的分析 被引量:8

Factors analysis on circadian rhythm of interdialytic blood pressure in maintenance hemodialysis patients
原文传递
导出
摘要 目的观察维持性血液透析患者透析间期血压节律可能存在的异常并讨论其影响因素。方法选择44例维持性血液透析患者,均于透析间期f透析前1d)进行24h动态血压监测,根据动态血压监测结果将患者分为3组:非高血压组、高血压控制组及高血压未控制组。监测或评估3组患者的血红蛋白(Hb)、血肌酐(Scr)、Kt/V、血清钙(Ca)、磷(P)、全段甲状旁腺素(iPTH)、透析间期体质量增加(IDWG)、Morisky依从性评分等。对相应的指标进行统计分析,筛选出影响血压节律的因素。结果(1)动态血压相关参数包括夜间血压下降率、收缩压和舒张压的夜间下降率、动态动脉硬化指数(AASI)、杓形血压比例在3组之间的差异无统计学意义。高血压未控制组的24h平均脉压比其他两组高[(80.06±13.41)比(53.00±7.73)、(57.85±21.97)mmHg,均P〈0.01]。(2)3组患者血压曲线均呈现“两峰一谷”的表现,高血压未控制组夜间血压下降不明显。(3)夜间收缩压下降率与血iPTH呈负相关(r=-0.349,P=0.0241。(4)44例患者中的全部10例杓型血压节律者的AASI与夜间舒张压下降率呈负相关(r=-0.748,P=0.0131。结论维持性血液透析患者夜间血压下降与甲状旁腺素及血管硬化程度有关。 Objective To describe the circadian profiles of interdialytic blood pressure in maintenance hemodialysis patients and to investigate its related factors. Methods Ambulatory blood pressure monitoring (ABPM) was conducted in forty-four patients on regular hemodialysis during interdialytic days. Three groups were identified with their ambulatory blood pressure: non-hypertension group, controlled hypertension group and uncontrolled hypertension group. Hemoglobin, creatinine, Kt/V, serum total calcium, serum phosphate, immunoreactive parathyroid hormone (iPTH), interdialytic weight gain and Morisky self-report scale etc. were assessed. Results (1) No significant difference was found in ABPM index ranged from decline in nocturnal systolic and diastolic blood pressure, AASI to dipper percentage in three groups. Nevertheless, 24-h average pulse pressure in uncontrolled hypertension group was higher than the other groups [(80.06±13.41 ) vs (53.00±7.73), (57.85±21.97) mm Hg, all P〈0.01]. (2) All the three groups showed the blood pressure profile of double-peak and trough. In the uncontrolled hypertension group, however, the nocturnal blood pressure decrease was not notable. (3) Nocturnal systolic blood pressure decline was negatively correlated to iPTH (r=-0.039, P〈0.05). (4) In ten dippers out pressure dec correlated to of all 44 patients, AASI was negatively correlated with nocturnal diastolic blood line (r=-0.748, P〈0.05). Conclusion Nocturnal blood pressure decline is iPTH and arterial sclerosis
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第4期235-239,共5页 Chinese Journal of Nephrology
关键词 肾透析 昼夜节律 高血压 动态血压监测 甲状旁腺激素 Renal dialysis Circadian rhythm Hypertension Ambulatory blood pressure monitoring Parathyroid hormone
  • 相关文献

参考文献14

  • 1李娅,冯晓蓓,章倩莹,任红,张文,陈晓农,陈楠.慢性肾脏病患者血压昼夜节律异常的研究[J].中华肾脏病杂志,2006,22(6):328-331. 被引量:40
  • 2Liu M, Takahashi H, Morita Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant, 2003,18:563-569.
  • 3Dolan E, Li Y, Thljs L, et al. Ambulatory arterial stiffness index: rationale and methodology. Blood Press Monit, 2006,11 : 103 - 105.
  • 4金翠燕,钱珠,陈莉莎,王宪衍.继发性高血压24小时动态血压研究[J].中华心血管病杂志,1999,27(3):200-203. 被引量:17
  • 5Lopez-Gomez JM, Villaverde M, Jofre R, et al. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patient. Kidney Int Suppl, 2005,67: s63-s68.
  • 6Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 1986,24:67-74.
  • 7Farmer CK, Goldsmith DJ, Cox J, et al. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant, 1997,12:2301-2307.
  • 8Letizia C, Ferrari P, Cotesta D, et al. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J Hum Hypertens, 2005,19: 901-906.
  • 9Barletta G, De Feo ML, Del Bene R, et al. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab, 2000,85: 1815-1821.
  • 10Covic A, Goldsmith DJ, Ackrill P. Analysis of blood pressure variability in long term hemodialysis patients using ambulatory blood pressure monitoring. Abstract Book of the 13th International Congress of Nephrology, Jerusalem, 1993,255.

二级参考文献14

  • 1张维忠,施海明,王瑞冬,余绮文,王治国,张麟,吴中玉.动态血压参数正常参照值协作研究[J].中华心血管病杂志,1995,23(5):325-328. 被引量:256
  • 2Chan N P,Circulation,1989年,80卷,341页
  • 3Martins D, Tareen N, Norris KC. The epidemiology of endstage renal disease among African Americans. Am J Med Sci,2002, 323:65-71.
  • 4Muirhead N. The rationale for early management of chronic renal insufficiency. Nephrol Dial Transplant, 2001, 16 Suppl 7 : 51-56.
  • 5National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1):S1-S266.
  • 6Hansen HP, Rossing P, Tarnow L, et al. Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. Kidney Int, 1996, 50:579-585.
  • 7Robles NR, Cancho B, Ruiz-Calero R, et al. Nighttime blood pressure fall in renal disease patients. Ren Fail, 2003,25 : 829-837.
  • 8Jensen LW, Pedersen EB. Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure. Blood Press, 1997, 6:332-342.
  • 9Timio M, Lolli S, Verdura C, et al. Circadian blood pressure changes in patients with chronic renal insufficiency : a prospective study. Ren Fail, 1993, 15:231-237.
  • 10Covic A, Goldsmith DJ. Ambulatory blood pressure measurement in the renal patient. Curt Hypertens Rep, 2002,4:369-376.

共引文献55

同被引文献110

  • 1张维忠,施海明,王瑞冬,余绮文,王治国,张麟,吴中玉.动态血压参数正常参照值协作研究[J].中华心血管病杂志,1995,23(5):325-328. 被引量:256
  • 2候凡凡.中国慢性肾脏疾病患者的心血管危险:目前的现状和对策[J].中国血液净化,2005,4(12):641-642. 被引量:6
  • 3李娅,冯晓蓓,章倩莹,任红,张文,陈晓农,陈楠.慢性肾脏病患者血压昼夜节律异常的研究[J].中华肾脏病杂志,2006,22(6):328-331. 被引量:40
  • 4陈正贵,孔祥廉,缪灿铭,郭应军,顾向明,孙健,马立坚.高血压患者血压昼夜节律消失与一氧化氮和内皮素关系的研究[J].中国医师杂志,2006,8(10):1345-1347. 被引量:12
  • 5Roberts MA. Dialysis patients without known cardiovascular disease have high cardiovascular mortality: analysis of the Australia and New Zealand dialysis and transplant (ANZDATA) registry. Program and abstracts of the American Society of Nephrology 2006 Annual Meeting, San Diego, California. Washington DC: American Society of Nephrology, 2006.
  • 6Sommerer C, Beimler J, Schwenger V, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest, 2007,37:350-356.
  • 7Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med, 2005,353:238-248.
  • 8Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int, 2006,70:1318-1324.
  • 9Takahashi A, Takase H, Toriyama T, et al. Candesartan, an angiotensin Ⅱ type- 1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant, 2006,21:2507- 2512.
  • 10Cice G, Ferrara L, D' Andrea A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol, 2003,41:1438-1444.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部